Walleye Trading LLC Novo Cure LTD Transaction History

Walleye Trading LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$11.13 - $15.78 $23,306 - $33,043	2,094 New	2,094 $31,000
Q1 2023 May 15, 2023	BUY	$56.44 - $118.81 $1.47 Million - $3.09 Million	25,992 New	25,992 $1.56 Million
Q4 2021 Feb 14, 2022	BUY	$75.08 - $121.99 $17,793 - $28,911	237 Added 2.18%	11,086 $832,000
Q3 2021 Nov 15, 2021	BUY	$116.17 - $194.55 $191,099 - $320,034	1,645 Added 17.87%	10,849 $1.26 Million
Q2 2021 Aug 16, 2021	BUY	$130.4 - $225.58 $722,024 - $1.25 Million	5,537 Added 151.0%	9,204 $2.04 Million
Q1 2021 May 17, 2021	SELL	$124.11 - $190.17 $93,827 - $143,768	-756 Reduced 17.09%	3,667 $485,000
Q2 2020 Aug 14, 2020	BUY	$57.2 - $74.41 $115,544 - $150,308	2,020 Added 84.06%	4,423 $262,000
Q1 2020 May 15, 2020	SELL	$57.05 - $95.75 $191,459 - $321,337	-3,356 Reduced 58.27%	2,403 $162,000
Q4 2019 Feb 14, 2020	SELL	$68.3 - $93.8 $675,760 - $928,057	-9,894 Reduced 63.21%	5,759 $485,000
Q3 2019 Nov 14, 2019	SELL	$61.86 - $97.8 $311,526 - $492,520	-5,036 Reduced 24.34%	15,653 $1.17 Million
Q2 2019 Aug 14, 2019	BUY	$42.22 - $63.23 $358,701 - $537,202	8,496 Added 69.68%	20,689 $1.31 Million
Q4 2018 Feb 14, 2019	BUY	$28.72 - $52.63 $350,182 - $641,717	12,193 New	12,193 $408,000

262

76.9M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.75B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.